8 research outputs found
Results of a SELA Planning Survey
This study arose from the need for member input into the development of the Southeastern Library Association’s (SELA) Strategic Plan. Additionally, the Planning and Development Committee felt it was important to obtain a better understanding of what services and activities the librarians in the southeast would like to see provided by the regional association. The Committee also recognized that it was important not only to ask for possible areas of improvement, but to also ask for ideas on how to achieve those improvements
A Simple Step: Integrating Library Reference and Instruction into Previously Established Academic Programs for Minority Students
Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways
Heterozygous mutations in NKX2.5, a homeobox transcription factor, were reported to cause secundum atrial septal defects and result in atrioventricular (AV) conduction block during postnatal life. To further characterize the role of NKX2.5 in cardiac morphogenesis, we sought additional mutations in groups of probands with cardiac anomalies and first-degree AV block, idiopathic AV block, or tetralogy of Fallot. We identified 7 novel mutations by sequence analysis of the NKX2.5-coding region in 26 individuals. Associated phenotypes included AV block, which was the primary manifestation of cardiac disease in nearly a quarter of affected individuals, as well as atrial septal defect and ventricular septal defect. Ventricular septal defect was associated with tetralogy of Fallot or double-outlet right ventricle in 3 individuals. Ebstein’s anomaly and other tricuspid valve abnormalities were also present. Mutations in human NKX2.5 cause a variety of cardiac anomalies and may account for a clinically significant portion of tetralogy of Fallot and idiopathic AV block. The coinheritance of NKX2.5 mutations with various congenital heart defects suggests that this transcription factor contributes to diverse cardiac developmental pathways. J. Clin. Invest. 104:1567–1573 (1999)